** Dental implant maker Straumann STMN.S falls 4% after the U.S. imposed 50% tariffs on Brazil and peer Align Technology ALGN.O cut its outlook and missed Q2 results expectations
** Straumann produces some of its value implants in Brazil, which means it is "likely to be impacted by these high tariffs," Sibylle Bischofberger, analyst at Vontobel, says
** Neodent value implants account for around 5% of total sales, but Straumann said relocation of production to the U.S. should be possible, Bischofberger adds
** Align cut its forecast for 2025, expecting revenue growth to be flat compared to 2024, compared to its previous guidance range of 3.5% to 5.5%
** It also reported revenue of $1.01 billion, missing analysts' estimate of $1.06 billion, according to LSEG data
** "Overall, the news is slightly negative," Bischofberger says
** Shares were down 4.68% at 0705 GMT; up to the previous session's close, shares down 6.5% YTD
(Reporting by Isabel Demetz)
((Isabel.demetz@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.